ANALYSIS OF TMLHE AND CARNITINE BIOSYNTHESIS FOR AUTISM DIAGNOSIS
    1.
    发明申请
    ANALYSIS OF TMLHE AND CARNITINE BIOSYNTHESIS FOR AUTISM DIAGNOSIS 审中-公开
    TMLHE和CARNITINE生物识别用于诊断的分析

    公开(公告)号:US20130005806A1

    公开(公告)日:2013-01-03

    申请号:US13525677

    申请日:2012-06-18

    CPC分类号: A61K31/205 A61K31/221

    摘要: Embodiments of the invention include determining whether an individual has autism spectrum disorder or is at risk for developing autism spectrum disorder or at risk for regression of or into autism spectrum disorder. Specific embodiments include the determination of indicative levels of carnitine or other metabolites in carnitine biosynthesis and may include assaying for mutations in TMLHE, including in exon 2, for example. In some cases one can assay for mutations in TMLHE in the absence of biochemical analysis of carnitine biosynthesis metabolites. An individual with deficiency in TMLHE and/or carnitine levels may be administered carnitine, acetylcarnitine, butyrobetaine, or a combination thereof, for example.

    摘要翻译: 本发明的实施方案包括确定个体是否具有自闭症谱系障碍或处于发展自闭症谱系障碍或处于自闭症谱系障碍的退化或自闭症风险的风险中。 具体实施方案包括确定肉碱生物合成中肉碱或其他代谢物的指示水平,并且可以包括测定TMLHE中的突变,包括例如外显子2中的突变。 在某些情况下,可以在不存在肉碱生物合成代谢产物的生物化学分析的情况下测定TMLHE中的突变。 例如,具有TMLHE和/或肉碱水平不足的个体可以给予肉碱,乙酰肉碱,丁子甜菜碱或其组合。